suspensie
Sponsors
Amsterdam UMC, AstraZeneca AB, Stichting Radboud University Medical Center, UZ Leuven
Conditions
Central serous chorioretinopathyChronic mucopurulent discharge and/or discomfort of the ocular prosthesis socketSevere CRSwNP patients with asthma.cataract
Phase 3
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-
Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients
with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps (ORCHID)
CompletedCTIS2023-507987-38-00
Start: 2021-10-14End: 2024-12-18Target: 79Updated: 2025-02-03
Pred Forte® versus placebo eye drops in chronic central serous chorioretinopathy trial (PICS trial)
Not yet recruitingCTIS2024-511575-15-00
Target: 40Updated: 2025-01-28
Phase 4
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
WithdrawnCTIS2023-504451-27-00
Target: 100Updated: 2023-06-15
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
CompletedCTIS2023-504451-27-01
Start: 2024-02-29End: 2024-09-14Target: 40Updated: 2023-10-18
Comparison of treatment with preservative-free dexamethasone 0.1% (Monofree Dexamethason) and diclofenac 0.1% (Dicloabak) eye drops versus preserved dexamethasone 0.1% (Maxidex) and diclofenac 0.1% (Voltaren Ophtha) eye drops after cataract surgery.
CompletedCTIS2024-517572-38-00
Start: 2018-10-03End: 2025-11-18Target: 100Updated: 2024-11-07